Correlation Between Novo Nordisk and Precigen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and Precigen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and Precigen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novo Nordisk AS and Precigen, you can compare the effects of market volatilities on Novo Nordisk and Precigen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of Precigen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and Precigen.

Diversification Opportunities for Novo Nordisk and Precigen

0.68
  Correlation Coefficient

Poor diversification

The 3 months correlation between Novo and Precigen is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and Precigen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Precigen and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with Precigen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Precigen has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and Precigen go up and down completely randomly.

Pair Corralation between Novo Nordisk and Precigen

Assuming the 90 days trading horizon Novo Nordisk AS is expected to under-perform the Precigen. But the stock apears to be less risky and, when comparing its historical volatility, Novo Nordisk AS is 2.45 times less risky than Precigen. The stock trades about -0.08 of its potential returns per unit of risk. The Precigen is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  77.00  in Precigen on August 30, 2024 and sell it today you would earn a total of  6.00  from holding Precigen or generate 7.79% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy95.65%
ValuesDaily Returns

Novo Nordisk AS  vs.  Precigen

 Performance 
       Timeline  
Novo Nordisk AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novo Nordisk AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Precigen 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Precigen has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Novo Nordisk and Precigen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Novo Nordisk and Precigen

The main advantage of trading using opposite Novo Nordisk and Precigen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, Precigen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Precigen will offset losses from the drop in Precigen's long position.
The idea behind Novo Nordisk AS and Precigen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments